LAQ824
CAS No. 404951-53-7
LAQ824 ( Dacinostat )
Catalog No. M14389 CAS No. 404951-53-7
LAQ824 (Dacinostat) is a novel HDAC inhibitor with IC50 of 32 nM and is known to activate the p21 promoter.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 56 | In Stock |
|
5MG | 101 | In Stock |
|
10MG | 170 | In Stock |
|
25MG | 305 | In Stock |
|
50MG | 462 | In Stock |
|
100MG | 669 | In Stock |
|
500MG | 1368 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLAQ824
-
NoteResearch use only, not for human use.
-
Brief DescriptionLAQ824 (Dacinostat) is a novel HDAC inhibitor with IC50 of 32 nM and is known to activate the p21 promoter.
-
DescriptionLAQ824 (Dacinostat) is a novel HDAC inhibitor with IC50 of 32 nM and is known to activate the p21 promoter.
-
SynonymsDacinostat
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number404951-53-7
-
Formula Weight379.46
-
Molecular FormulaC22H25N3O3
-
Purity>98%(HPLC)
-
SolubilityDMSO: 76 mg/mL (200.28 mM)
-
SMILESO=C(NO)/C=C/C1=CC=C(CN(CCO)CCC2=CNC3=C2C=CC=C3)C=C1
-
Chemical Name(2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Atadja P, et al. Y Res, 2004, 64(2), 689-695.
molnova catalog
related products
-
GSK-3117391
GSK-3117391 (CHR-5154) is a novel macrophage-targeted HDAC inhibitor.
-
BRD 8184
BRD 8184 is a potent, selective HDAC6 inhibitor with IC50 of 8 nM.
-
ACY-738
ACY-738 (ACY738) is a potent and specific HDAC6 inhibitor (IC50=1.7 nM) with improved brain bioavailability; displays 60-1500 fold selectivity over class I HDACs.